Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Unexpected Drug-Induced Liver Injury Associated With MenoFit: A Synbiotic Menopause Supplement.

Autor: Dadlani A; Section of Gastroenterology and Hepatology, Margaret M. and Albert B. Alkek Department of Medicine, Baylor College of Medicine, Houston, TX.; Division of Abdominal Transplantation, Michael E. DeBakey Department of Surgery, Baylor College of Medicine, Houston, TX., Anudu A; Section of Gastroenterology and Hepatology, Margaret M. and Albert B. Alkek Department of Medicine, Baylor College of Medicine, Houston, TX.; Division of Abdominal Transplantation, Michael E. DeBakey Department of Surgery, Baylor College of Medicine, Houston, TX., Marginean EC; Department of Pathology and Immunology, Baylor St. Luke's Hospital, Baylor College of Medicine, Houston, TX.

Publikováno v: ACG case reports journal [ACG Case Rep J] 2023 Sep 23; Vol. 10 (9), pp. e01153. Date of Electronic Publication: 2023 Sep 23 (Print Publication: 2023).

Phosphorylated transducer and activator of transcription-3 (pSTAT3) immunohistochemical expression in paired primary and metastatic colorectal cancer.

Autor: Marginean EC; The Ottawa Hospital Cancer Centre, 501 Smyth Road, Ottawa ON K1H 8L6 Canada; Ottawa Hospital Research Institute, 1053 Carling Ave, Ottawa, ON K1Y 4E9. Electronic address: celia.marginean@providence.org., Gotfrit J; The Ottawa Hospital Cancer Centre, 501 Smyth Road, Ottawa ON K1H 8L6 Canada; Ottawa Hospital Research Institute, 1053 Carling Ave, Ottawa, ON K1Y 4E9. Electronic address: jgotfrit@toh.ca., Marginean H; The Ottawa Hospital Cancer Centre, 501 Smyth Road, Ottawa ON K1H 8L6 Canada; Ottawa Hospital Research Institute, 1053 Carling Ave, Ottawa, ON K1Y 4E9. Electronic address: hmarginean@toh.ca., Yokom DW; The Ottawa Hospital Cancer Centre, 501 Smyth Road, Ottawa ON K1H 8L6 Canada; Ottawa Hospital Research Institute, 1053 Carling Ave, Ottawa, ON K1Y 4E9. Electronic address: dwyokom@gmail.com., Bateman JJ; Ottawa Hospital Research Institute, 1053 Carling Ave, Ottawa, ON K1Y 4E9; The Ottawa Hospital, Department of Pathology, 501 Smyth Road, Ottawa ON K1H 8L6 Canada. Electronic address: jbateman@toh.ca., Daneshmand M; The Ottawa Hospital Cancer Centre, 501 Smyth Road, Ottawa ON K1H 8L6 Canada; Ottawa Hospital Research Institute, 1053 Carling Ave, Ottawa, ON K1Y 4E9. Electronic address: manijeh_d@hotmail.com., Sud S; The Ottawa Hospital Cancer Centre, 501 Smyth Road, Ottawa ON K1H 8L6 Canada; Ottawa Hospital Research Institute, 1053 Carling Ave, Ottawa, ON K1Y 4E9. Electronic address: shellysud@me.com., Gown AM; PhenoPath Laboratories, 551 N. 34th Street Seattle 98103 USA. Electronic address: gown@phenopath.com., Jonker D; The Ottawa Hospital Cancer Centre, 501 Smyth Road, Ottawa ON K1H 8L6 Canada; Ottawa Hospital Research Institute, 1053 Carling Ave, Ottawa, ON K1Y 4E9. Electronic address: djonker@toh.ca., Asmis T; The Ottawa Hospital Cancer Centre, 501 Smyth Road, Ottawa ON K1H 8L6 Canada; Ottawa Hospital Research Institute, 1053 Carling Ave, Ottawa, ON K1Y 4E9. Electronic address: tasmis@toh.ca., Goodwin RA; The Ottawa Hospital Cancer Centre, 501 Smyth Road, Ottawa ON K1H 8L6 Canada; Ottawa Hospital Research Institute, 1053 Carling Ave, Ottawa, ON K1Y 4E9. Electronic address: rgoodwin@toh.ca.

Publikováno v: Translational oncology [Transl Oncol] 2021 Feb; Vol. 14 (2), pp. 100996. Date of Electronic Publication: 2020 Dec 17.

SET ER/PR : a robust 18-gene predictor for sensitivity to endocrine therapy for metastatic breast cancer.

Autor: Sinn BV; 1Department of Pathology and Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX USA.; Department of Pathology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institut of Health, Berlin, Germany., Fu C; 1Department of Pathology and Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX USA., Lau R; 1Department of Pathology and Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX USA., Litton J; 3Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX USA., Tsai TH; 1Department of Pathology and Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX USA., Murthy R; 3Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX USA., Tam A; 4Department of Interventional Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX USA., Andreopoulou E; 3Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX USA.; 5Department of Medicine, Weill Cornell Medicine, New York, NY USA., Gong Y; 1Department of Pathology and Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX USA., Murthy R; 4Department of Interventional Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX USA., Gould R; 1Department of Pathology and Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX USA., Zhang Y; 1Department of Pathology and Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX USA., King TA; 6Department of Surgery, Brigham and Women's Hospital and Dana Farber Cancer Institute, Boston, MA USA., Viale A; 7Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, NY USA., Andrade V; 7Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, NY USA.; 8Department of Pathology, AC Camargo Cancer Center, Sao Paulo, Brazil., Giri D; 7Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, NY USA., Salgado R; Department of Pathology, GZA-ZNA, Antwerp, Belgium.; 10Division of Research, Peter Mac Callum Cancer Centre, Melbourne, Australia., Laios I; 11Department of Pathology, Institut Jules Bordet, Brussels, Belgium., Sotiriou C; 12Translational Breast Cancer Laboratory, Institut Jules Bordet, Brussels, Belgium., Marginean EC; 13Department of Pathology and Surgery, University of Ottawa, Ottawa, Canada., Kwiatkowski DN; 3Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX USA., Layman RM; 3Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX USA., Booser D; 3Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX USA., Hatzis C; 14Department of Medicine, Yale University School of Medicine, New Haven, CT USA., Vicente Valero V; 3Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX USA., Fraser Symmans W; 1Department of Pathology and Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX USA.

Publikováno v: NPJ breast cancer [NPJ Breast Cancer] 2019 May 30; Vol. 5, pp. 16. Date of Electronic Publication: 2019 May 30 (Print Publication: 2019).

Relevance of histology in the diagnosis of reflux esophagitis.

Autor: Tripathi M; Department of Histopathology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK., Streutker CJ; Department of Laboratory Medicine, St. Michael's Hospital, University of Toronto, Toronto, Ontario, Canada., Marginean EC; Department of Laboratory Medicine, Ottawa Hospital, Ottawa, Ontario, Canada.

Publikováno v: Annals of the New York Academy of Sciences [Ann N Y Acad Sci] 2018 Dec; Vol. 1434 (1), pp. 94-101. Date of Electronic Publication: 2018 May 16.